Clinical Trial: Impact of Leukoreduction Timing on Plasma Citrullinated Histone H3 (H3cit) Dynamics and Red Blood Cell Storage Lesions

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07821736) titled 'Impact of Leukoreduction Timing on Plasma Citrullinated Histone H3 (H3cit) Dynamics and Red Blood Cell Storage Lesions' on Sept. 10.

Brief Summary: Impact of Leukoreduction Timing on Plasma Citrullinated Histone H3 (H3cit) Dynamics and Red Blood Cell Storage Lesions To measure H3cit levels immediately after filtration on Days 0, 1, 3, and 5. To measure H3cit levels during storage at mid-storage and shelf-life end To correlate H3cit levels with standard blood storage markers

Study Start Date: Nov. 01

Study Type: INTERVENTIONAL

Condition: Healthy Donors

Intervention: OTHER: H3Cit

To measure H3cit levels during storage at mid-s...